William Blair β Full Portfolio
3 tracked investments Β· listed companies and verified rows first
Neurogene develops gene therapy treatments for rare neurological diseases.
BiotechDeep TechDigital HealthLongevityMedical DevicesNew York, US
Rachel McMinn(Founder and Chief Executive Officer)inRachel McMinn, Ph.D.(Founder and Chief Executive Officer)
BoardCory Freedland(Director)inStephen Biggar(Director)
Co-investorsEcoR1 CapitalSamsara BioCapitalCasdin CapitalREDMILERTW Investments L.P.
Halo operates a platform that gives financial advisors and institutions access to protective investment products such as Structured Notes, annuities, and Structured Note SMAs, including tools to create custom Structured Notes.
Enterprise SoftwareFintechSaaSChicago, US
Jason Barsema(Executive Officer, Director)inBiju Kulathakal(Executive Officer, Director)in
BoardJames P. Fortescue(Director)Abhinav Tiwari(Director)Dennis Barsema(Director)
Co-investorsG SquaredOwl CapitalAbu Dhabi Catalyst PartnersAllianz Life Ventures
Integer Technologies offers a plug-and-play platform to remotely monitor, manage, and optimize energy installations such as heat pumps, solar panels, and air handling systems.
AI & Machine LearningCleantechEnergyEindhoven, NL
Co-investorsBOMAllianceBernstein
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.